Geode Capital Management
RDHL

Geode Capital Management’s Redhill Biopharma RDHL Stock Holding History

Geode Capital Management’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-42
Closed -$5K – 4823
2022
Q4 		$5K Hold
42
– – ﹤0.01% 4883
2022
Q3 		$20K Hold
42
– – ﹤0.01% 4917
2022
Q2 		$36K Hold
42
– – ﹤0.01% 4849
2022
Q1 		$104K Buy
42
+16
+62% +$37.9K ﹤0.01% 4648
2021
Q4 		$68K Sell
26
-1
-4% -$4K ﹤0.01% 4809
2021
Q3 		$124K Hold
27
– – ﹤0.01% 4613
2021
Q2 		$187K Buy
27
+2
+8% +$13.8K ﹤0.01% 4363
2021
Q1 		$180K Buy
25
+4
+19% +$33.6K ﹤0.01% 4146
2020
Q4 		$168K Hold
21
– – ﹤0.01% 3928
2020
Q3 		$213K Buy
21
+1
+5% +$8.2K ﹤0.01% 3698
2020
Q2 		$134K Buy
20
+3
+18% +$20.7K ﹤0.01% 3780
2020
Q1 		$76K Hold
17
– – ﹤0.01% 3841
2019
Q4 		$102K Hold
17
– – ﹤0.01% 3976
2019
Q3 		$118K Hold
17
– – ﹤0.01% 3909
2019
Q2 		$109K Buy
17
+4
+31% +$30.8K ﹤0.01% 3940
2019
Q1 		$110K Hold
13
– – ﹤0.01% 3878
2018
Q4 		$73K Buy
+13
New +$99.6K ﹤0.01% 3918

Other funds holding RDHL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Geode Capital Management's RDHL Position: Q1 2023 in Review

Geode Capital Management sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 42 shares — an estimated $5K sold.

Geode Capital Management first reported a position in RDHL in Q4 2018 and held it in 17 quarters. The position peaked at $213K in Q3 2020. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

  • Geode Capital Management reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
  • Geode Capital Management sold 42 Redhill Biopharma shares in Q1 2023, an estimated $5K.
  • Geode Capital Management first reported a position in Redhill Biopharma in Q4 2018 and held it in 17 quarters.
  • Geode Capital Management's Redhill Biopharma position peaked at $213K in Q3 2020.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.